Fenghua Gao
Zhengzhou, 450008, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Survival Benefit of Relmacabtagene Autoleucel Versus Usual Care in Relapsed/Refractory Follicular Lymphoma: A Matching-Adjusted Indirect Analysis.
Journal: Hematological oncology
Published: November 23, 2024
Time to lymphoma treatment within 24 months in 'watch and wait' follicular lymphoma is associated with inferior outcomes: A multicentre analysis.
Journal: British journal of haematology
Published: May 10, 2024
Epidemiological features and prognosis for primary gastrointestinal follicular lymphoma.
Journal: British journal of haematology
Published: December 02, 2023
Integrative genomic and transcriptomic analysis reveals genetic alterations associated with the early progression of follicular lymphoma.
Journal: British journal of haematology
Published: April 26, 2023
The prognostic index PRIMA-PI combined with Ki67 as a better predictor of progression of disease within 24 months in follicular lymphoma.
Journal: Frontiers in oncology
Published: November 05, 2022
Correction to: Risk factors for POD24 in patients with previously untreated follicular lymphoma: a systematic review and meta‑analysis.
Journal: Annals of hematology
Published: October 18, 2022
m6A-Regulator Expression Signatures Identify a Subset of Follicular Lymphoma Harboring an Exhausted Tumor Microenvironment.
Journal: Frontiers in immunology
Published: April 18, 2022
Screening of Adverse Prognostic Factors and Construction of Prognostic Index in Previously Untreated Concurrent Follicular Lymphoma and Diffuse Large B-Cell Lymphoma.
Journal: BioMed research international
Published: March 04, 2022
Clinical features and outcomes of patients with follicular lymphoma: A real-world study of 926 patients in China.
Journal: Frontiers in oncology
Published: January 26, 2022
Fotemustine-based therapy in combination with rituximab as a first-line induction chemotherapy followed by WBRT for newly diagnosed primary central nervous system lymphoma: a prospective phase II trial.
Journal: Cancer biology & medicine
Published: October 11, 2021
Showing 1-12 of 12
Last Updated: 09/26/2026